Aytu Biopharma (AYTU) Capital Expenditures (2015 - 2025)
Aytu Biopharma (AYTU) reported Capital Expenditures of $17000.0 for Q4 2025, up 183.33% year-over-year from $6000.0 in Q4 2024, and little changed quarter-over-quarter from $17000.0 in Q2 2025.
Aytu Biopharma (AYTU) Capital Expenditures (2015 - 2025) Analysis & Trends
Aytu Biopharma (AYTU) has 9 years of Capital Expenditures data on file, last reported at $17000.0 in Q4 2025.
- Capital Expenditures for Q4 2025 came in at $17000.0, up 183.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $34000.0 (down 93.7% YoY), and the FY2025 annual result was $228000.0, down 30.7% from the prior year.
- Capital Expenditures steadied at $17000.0 in Q4 2025 per AYTU's latest filing, from $17000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $329000.0 in Q2 2024 and troughed at -$13.1 million in Q2 2021.
- A 3-year average of -$1.8 million and a median of $17000.0 in 2025 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2021 and 2025: Capital Expenditures slumped 123.21% in 2021, then soared 183.33% in 2025.
- A 3-year view of Capital Expenditures shows it stood at -$13.1 million in 2021, then surged by 100.05% to $6000.0 in 2024, then soared by 183.33% to $17000.0 in 2025.
- Business Quant data shows AYTU's Capital Expenditures at $17000.0 in Q4 2025, $17000.0 in Q2 2025, and $69000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 168.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 110.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 100.80 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 9.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 51.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.09 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 8.83 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.04 Mn |
| 10 | Aytu Biopharma | 24.60 Mn | -2.12 Mn | 7.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17,000.00 |
| Dec 31, 2025 | 17,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Mar 31, 2025 | 69,000.00 |
| Mar 31, 2025 | 69,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Sep 30, 2024 | 136,000.00 |
| Sep 30, 2024 | 136,000.00 |
| Jun 30, 2024 | 329,000.00 |
| Jun 30, 2024 | 329,000.00 |
| Jun 30, 2021 | -13.06 Mn |
| Jun 30, 2021 | -13.06 Mn |
| Jun 30, 2020 | -5.85 Mn |
| Jun 30, 2020 | -5.85 Mn |
| Mar 31, 2020 | 1.35 Mn |
| Mar 31, 2020 | 1.35 Mn |
| Dec 31, 2019 | 4.50 Mn |
| Dec 31, 2019 | 4.50 Mn |